Yafei Liu

1.3k total citations
11 papers, 335 citations indexed

About

Yafei Liu is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Yafei Liu has authored 11 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 3 papers in Molecular Biology and 3 papers in Epidemiology. Recurrent topics in Yafei Liu's work include COVID-19 Clinical Research Studies (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Clostridium difficile and Clostridium perfringens research (3 papers). Yafei Liu is often cited by papers focused on COVID-19 Clinical Research Studies (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Clostridium difficile and Clostridium perfringens research (3 papers). Yafei Liu collaborates with scholars based in China, Japan and Canada. Yafei Liu's co-authors include Bota Cui, Cicilia Marcella, Ting Zhang, Faming Zhang, Pan Li, Zhe Zhao, Haoran Yin, Guozhong Ji, Yaoyao Chen and Lei Cheng and has published in prestigious journals such as The Journal of Infectious Diseases, Frontiers in Immunology and Vaccine.

In The Last Decade

Yafei Liu

8 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yafei Liu China 7 241 204 76 66 33 11 335
Arthur Kastl United States 5 120 0.5× 187 0.9× 70 0.9× 64 1.0× 44 1.3× 9 368
Esi Lamousé‐Smith United States 9 124 0.5× 191 0.9× 60 0.8× 60 0.9× 62 1.9× 18 422
Sophie Valkenburg Australia 8 127 0.5× 110 0.5× 11 0.1× 86 1.3× 20 0.6× 10 328
Sakari Pöysti Finland 6 88 0.4× 260 1.3× 31 0.4× 27 0.4× 40 1.2× 8 375
Yangqing Peng United States 4 109 0.5× 236 1.2× 37 0.5× 40 0.6× 32 1.0× 7 369
Elisa Schiavoni Italy 8 95 0.4× 153 0.8× 68 0.9× 75 1.1× 48 1.5× 23 329
Andreas Zollner Austria 6 185 0.8× 87 0.4× 7 0.1× 25 0.4× 17 0.5× 10 335
Koen Wortelboer Netherlands 10 149 0.6× 338 1.7× 73 1.0× 52 0.8× 36 1.1× 19 446
Xiaobing Shen China 10 103 0.4× 158 0.8× 33 0.4× 57 0.9× 31 0.9× 31 319
Ashley Alexander United States 6 270 1.1× 154 0.8× 107 1.4× 138 2.1× 71 2.2× 11 335

Countries citing papers authored by Yafei Liu

Since Specialization
Citations

This map shows the geographic impact of Yafei Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yafei Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yafei Liu more than expected).

Fields of papers citing papers by Yafei Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yafei Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yafei Liu. The network helps show where Yafei Liu may publish in the future.

Co-authorship network of co-authors of Yafei Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Yafei Liu. A scholar is included among the top collaborators of Yafei Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yafei Liu. Yafei Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
2.
Xiang, Zixuan, Xiangyun Li, Xiaoli Wang, et al.. (2025). Fusobacterium nucleatum exacerbates colitis via STAT3 activation induced by Acetyl-CoA accumulation. Gut Microbes. 17(1). 2489070–2489070. 5 indexed citations
3.
4.
Liu, Jiankai, Baoying Huang, Danni Wang, et al.. (2023). Immunogenicity and Safety of a SARS-CoV-2 Inactivated Vaccine KCONVAC in Chinese Children: Randomized, Double-blind, Placebo-controlled Phase 1 and 2 Trials. The Pediatric Infectious Disease Journal. 42(12). 1136–1142.
5.
Kohyama, Masako, Tatsuya Suzuki, Wataru Nakai, et al.. (2022). SARS-CoV-2 ORF8 is a viral cytokine regulating immune responses. International Immunology. 35(1). 43–52. 12 indexed citations
6.
Liu, Yafei & Hisashi Arase. (2022). Neutralizing and enhancing antibodies against SARS-CoV-2. Inflammation and Regeneration. 42(1). 58–58. 9 indexed citations
7.
Li, Mengting, Hongfei Zhu, Yafei Liu, et al.. (2022). Role of Traditional Chinese Medicine in Treating Severe or Critical COVID-19: A Systematic Review of Randomized Controlled Trials and Observational Studies. Frontiers in Pharmacology. 13. 926189–926189. 15 indexed citations
8.
Liu, Jiankai, Baoying Huang, Yafei Liu, et al.. (2021). Immunogenicity and Safety of a 3-Dose Regimen of a SARS-CoV-2 Inactivated Vaccine in Adults: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial. The Journal of Infectious Diseases. 225(10). 1701–1709. 10 indexed citations
9.
10.
Li, Qianqian, Xiao Ding, Cicilia Marcella, et al.. (2020). Fecal Microbiota Transplantation for Ulcerative Colitis: The Optimum Timing and Gut Microbiota as Predictors for Long-Term Clinical Outcomes. Clinical and Translational Gastroenterology. 11(8). e00224–e00224. 38 indexed citations
11.
Zhang, Ting, Gaochen Lu, Zhe Zhao, et al.. (2020). Washed microbiota transplantation vs. manual fecal microbiota transplantation: clinical findings, animal studies and in vitro screening. Protein & Cell. 11(4). 251–266. 208 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arthur Kastl Breakdown of academic impact, for papers by Esi Lamousé‐Smith Breakdown of academic impact, for papers by Sophie Valkenburg Breakdown of academic impact, for papers by Sakari Pöysti Breakdown of academic impact, for papers by Yangqing Peng Breakdown of academic impact, for papers by Elisa Schiavoni Breakdown of academic impact, for papers by Andreas Zollner Breakdown of academic impact, for papers by Koen Wortelboer Breakdown of academic impact, for papers by Xiaobing Shen Breakdown of academic impact, for papers by Ashley Alexander
Rankless by CCL
2026